Αρχειοθήκη ιστολογίου

Δευτέρα 4 Σεπτεμβρίου 2017

FDA approves gemtuzumab ozagamicin for treatment of acute myeloid leukaemia

The U.S. Food and Drug Administration has approved gemtuzumab ozogamicin for the treatment of adults with newly diagnosed acute myeloid leukaemia whose tumours express the CD33 antigen (CD33-positive AML). The FDA also approved gemtuzumab ozogamicin...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2x5g0d2
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader